Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-09-20

FDA Approved: BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE — Original Application (Acella Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved an original application for a generic combination product containing brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan h…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brompheniramine maleate, pseudoephedrine hydrochloride and dextromethorphan hydrobromide (brompheniramine maleate; pseudoephedrine hydrochloride; dextromethorphan hydrobromide)

Snippet

ORIG AP for BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, DEXTROMETHORPHAN HYDROBROMIDE (BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE, AND DEXTROMETHORPHAN HYDROBROMIDE)